Publication date: Available online 23 June 2017 Source:Best Practice & Research Clinical Anaesthesiology Author(s): Sharon L. McCartney, Chetan Patel, J. Mauricio Del Rio Cardiac transplantation remains the gold standard in the treatment of advanced heart failure. With advances in immunosuppression, long-term outcomes continue to improve despite older and higher-risk recipients. The median survival after heart transplantation in the adult is now 10.7 years. While early graft failure and multi-organ system dysfunction are the most important causes of early mortality; malignancy, rejection, infection, and cardiac allograft vasculopathy contribute to late mortality. Chronic renal dysfunction is common after heart transplantation and occurs in up to 68% of patients by year 10, with 6....
from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sD0MZs
via IFTTT
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
▼
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,